A-shares rose collectively on the 6th: innovative drugs led the gains, over 4,200 stocks in the green, market activity increased

NightAirdropper · 2026-03-08T01:50:05+00:00

Today, the A-share market performed positively, with all three major indices rising. The Shanghai Composite Index increased by 0.38%, and the Shenzhen Component Index rose by 0.59%. Market trading volume reached 2.22 trillion yuan, with over 4,200 stocks advancing. The innovative medicine sector performed notably, attracting investor attention, while several other sectors were also active. However, oil and gas, non-ferrous metals, and other sectors showed weaker performance.

NightAirdropper

2026-03-08 01:50:05

Abstract generation in progress

The A-share market showed a positive trend today, with the three major indices gradually rising after a low opening, ultimately closing in the green. Specifically, the Shanghai Composite Index closed up by 0.38%, the Shenzhen Component Index rose slightly more by 0.59%, and the ChiNext Index followed closely, increasing by 0.38%.

Overall market performance saw a significant increase in trading activity, with total market turnover reaching 2.22 trillion yuan. In terms of individual stocks, a broad rally was observed, with over 4,200 stocks rising, creating a lively market atmosphere.

In sector performance, the innovative medicine sector stood out as the star today, with notable gains attracting many investors’ attention. Meanwhile, multiple themes such as consumer goods, anti-tariff measures, smart grids, phosphate chemicals, low-altitude economy, AI applications, and financial technology also performed actively, adding bright spots to the market. However, not all sectors performed strongly; oil and gas, non-ferrous metals, shipping, and coal sectors showed relative weakness, indicating some divergence.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes